KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Petmed Express (PETS) Shares Outstanding (Weighted Average) (2016 - 2025)

Petmed Express has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $20.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1.21% year-over-year to $20.9 million; the TTM value through Dec 2025 reached $20.9 million, up 1.21%, while the annual FY2025 figure was $20.6 million, 0.98% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $20.9 million at Petmed Express, roughly flat from $20.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $20.9 million in Q3 2025 and troughed at $20.1 million in Q1 2021.
  • A 5-year average of $20.4 million and a median of $20.3 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.09% in 2021 and later increased 1.41% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $20.2 million in 2021, then grew by 0.46% to $20.3 million in 2022, then increased by 0.39% to $20.4 million in 2023, then rose by 1.25% to $20.6 million in 2024, then increased by 1.21% to $20.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PETS at $20.9 million in Q4 2025, $20.9 million in Q3 2025, and $20.8 million in Q2 2025.